Clinical trials
Phase 3 Postoperative Nausea and Vomiting trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Unknown status | 9 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acacia Pharma Ltd | 5 |
| Balgrist University Hospital | 2 |
| GlaxoSmithKline | 2 |
| Helsinn Healthcare SA | 2 |
| Instituto Mexicano del Seguro Social | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Qilu Pharmaceutical (Hainan) Co., Ltd. | 2 |
| Selcuk University | 2 |
| Ain Shams University | 1 |
| Al-Azhar University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Postoperative Nausea and Vomiting | 53 |
| Vomiting | 10 |
| Postoperative Pain | 9 |
| Nausea | 4 |
| Agnosia | 3 |
| Emergence Delirium | 2 |
| Pain | 2 |
| Adenomyosis | 1 |
| Breast Neoplasms | 1 |
| Fatigue | 1 |
Trials
Showing 76 to 53 of 53. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.